Safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease—Results of a multicenter open trial

AIM: To evaluate the effect of aripiprazole on psychosis and motor function in Japanese Parkinson's disease patients. METHODS: Patients with Parkinson's disease and hallucinations and/or delusions were enrolled. They were administered aripiprazole 3 mg/day, with dosage increased or reduced...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashihara, Kenichi, Maeda, Tetsuya, Yoshida, Kazuto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216359/
https://www.ncbi.nlm.nih.gov/pubmed/35226404
http://dx.doi.org/10.1002/npr2.12235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216359/
https://www.ncbi.nlm.nih.gov/pubmed/35226404
http://dx.doi.org/10.1002/npr2.12235

Ejemplares similares